December 19th 2008 | Biologics, Treatment | 0 Comments
Statement issued today from Centocor about Stelara (ustekinumab):
Centocor, Inc., announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its Biologics License Application (BLA) for ustekinumab. …
The Complete Response letter requests additional information, including a proposal by Centocor for a Risk Evaluation and Mitigation Strategy (REMS). … The ustekinumab
READ THE FULL POST
December 11th 2008 | Patient Stories | 0 Comments
Have you checked out Kevin’s profile on our 2008 Calendar website? Kevin has a hard time living with psoriasis. It’s a story that will be painfully familiar to many, many people living with psoriasis.
We’re grateful that Kevin was willing to speak so candidly about his feelings. Let’s hope he and everyone else
READ THE FULL POST
November 22nd 2008 | Get involved | 0 Comments
With Christmas and Hanukkah just around the corner, online shopping will soon be at fever pitch. Now you can earn donations for Psoriasis Cure Now programs every time you shop online! Simply click on this link to get started: http://www.goodshop.com/?charityid=858078 . All the top stores are there — more than 500 in all!
READ THE FULL POST
November 22nd 2008 | Patient Stories | 0 Comments
In case you missed it, we thought we’d remind you to check out our profiles of Darlene and Brittany–mother and daughter, both battling psoriasis and psoriatic arthritis. Mom is trying to go without treatment, daughter is on a biologic. Two different approaches in one great family.
November 20th 2008 | Alternative/buyer beware/natural | 0 Comments
Researchers in Taiwan have found that an ointment containing indigo naturalis, a traditional Chinese herbal remedy, outperformed a plain ointment in improving a spot, or plaque, of psoriasis. The test subjects applied the indigo ointment to a psoriasis plaque on one side of their body, and a plain ointment to a comparable plaque on
READ THE FULL POST
November 17th 2008 | Biologics, Immune system | 0 Comments
From a Genentech news release:
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva (efalizumab) for approximately four years for treatment of
READ THE FULL POST
November 16th 2008 | Impact of psoriasis, Triggers/environment | 0 Comments
Not really news for most psoriasis patients, but still interesting to see studied:
Stress has been found to activate the immune system in the skin of mice, causing them to itch.
The same likely holds true for humans, researchers say.
… The immune cells in skin can overreact, though, causing inflammatory skin diseases such as dermatitis and psoriasis.
November 13th 2008 | Psoriasis Research, Public policy issues | 0 Comments
As Congress is approaching $1,000,000,000,000 in taxpayer-funded bailouts to companies run by people who made bad decisions, biomedical research funding by the federal government has been stagnant for nearly 5 years. The latest Congressional effort, to give another $50 billion to the Big Three automakers, equals almost two years of the entire federal government’s
READ THE FULL POST
September 30th 2008 | Alternative/buyer beware/natural, Health care system, Treatment | 0 Comments
From the New York Times:
Can online information be trusted? The answer, increasingly, is yes. In a study earlier this year, a report in the journal Cancer looked at 343 Web pages about breast cancer that came up in online searches. The researchers found 41 inaccurate statements on 18 sites — an error rate of 5.2
READ THE FULL POST
September 21st 2008 | Patient Stories | 0 Comments
Have you checked out our September 2008 psoriasis patient profile? Lynda has lived with psoriasis for more than 15 years, but is currently enjoying treatment success. She’s not sure it will last, but is enjoying it while she can.
She also manages to be a good sport about the indignities many psoriasis patients face.
READ THE FULL POST
